Cargando…

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy

BACKGROUND: Subclinical infection with Mycobacterium leprae is one potential source of leprosy transmission, and post-exposure prophylaxis (PEP) regimens have been proposed to control this source. Because PEP trials require considerable investment, we applied a sensitive variation of the kinetic mou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenz, Shannon M., Collins, Jaymes H., Ray, Nashone A., Hagge, Deanna A., Lahiri, Ramanuj, Adams, Linda B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494095/ https://www.ncbi.nlm.nih.gov/pubmed/32936818 http://dx.doi.org/10.1371/journal.pntd.0008583

Ejemplares similares

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice
por: Almeida, Deepak, et al.
Publicado: (2011)

Novel approaches in the treatment of Hansen’s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States
por: Franco-Paredes, Carlos, et al.
Publicado: (2022)

IL-10 and NOS2 Modulate Antigen-Specific Reactivity and Nerve Infiltration by T Cells in Experimental Leprosy
por: Hagge, Deanna A., et al.
Publicado: (2014)

1983. Oral Therapy with Rifampin Associated with Minocycline or Moxifloxacin in Vertebral Osteomyelitis due to Gram-Positive Micro-organisms: A Retrospective Study of 64 Cases
por: Gaspard, Laura, et al.
Publicado: (2018)

In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection
por: Albano, Mariana, et al.
Publicado: (2021)

A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis
por: Conde, Marcus B., et al.
Publicado: (2016)

1586. In Vitro Activity of Rifampin, Rifabutin, Rifapentine, and Rifaximin Against Biofilms Formed by Staphylococci Isolated from Prosthetic Joint Infection
por: Albano, Mariana, et al.
Publicado: (2019)

An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++
por: Mieras, Liesbeth F, et al.
Publicado: (2018)

Mycobacterium lepromatosis as Cause of Leprosy, Colombia
por: Cardona-Castro, Nora, et al.
Publicado: (2022)

Assessment of vocation of rifabutin and rifapentine in replace of rifampcin in drug resistance leprosy patients: a molecular simulation study
por: Mohanty, Partha Sarathi, et al.
Publicado: (2017)

Cohort Study of Intracameral Moxifloxacin in Postoperative Endophthalmitis Prophylaxis
por: Galvis, Virgilio, et al.
Publicado: (2014)

Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
por: Greimel, Felix, et al.
Publicado: (2017)

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
por: McClintock, Adelaide H., et al.
Publicado: (2017)

2419. Standard vs. Alternative Therapy for Stenotrophomonas maltophilia Infections: Focus on Trimethoprim–Sulfamethoxazole, Minocycline, and Moxifloxacin Monotherapy
por: Badwal, Jasmin, et al.
Publicado: (2018)

810. Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations
por: Gerges, Bahgat, et al.
Publicado: (2020)

2453. Repeated Exposures to Minocycline/Rifampin and + Chlorhexidine Combination Used to Coat Catheters Fails to Induce Antimicrobial Resistance
por: Vargas-Cruz, Nylev, et al.
Publicado: (2018)

Clarithromycin–Rifampin-Based Treatment for Nontuberculous Mycobacteria Infections in Immunocompromised Patients who Require Concomitant CYP-Metabolized Medications
por: Gonzalez-Bocco, Isabel H, et al.
Publicado: (2021)

Diagnosis and Treatment of Leprosy Reactions in Integrated Services - The Patients' Perspective in Nepal
por: Raffe, Sonia F., et al.
Publicado: (2013)

Molecular Assays for Determining Mycobacterium leprae Viability in Tissues of Experimentally Infected Mice
por: Davis, Grace L., et al.
Publicado: (2013)

Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis
por: Montezuma, Thais, et al.
Publicado: (2023)

Rifapentine-Proliposomes for Inhalation: In Vitro and In Vivo Toxicity
por: Patil-Gadhe, Arpana A., et al.
Publicado: (2014)

Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention
por: Podany, Anthony T.
Publicado: (2020)

1399. Clarithromycin–Rifampin-based Treatment for Non-tuberculous Mycobacterial Infections in Immunocompromised Patients Who Require Concomitant CYP-Metabolized Medications
por: Gonzalez-Bocco, Isabel H, et al.
Publicado: (2021)

Effect of Administration of Moxifloxacin plus Rifampin against Mycobacterium tuberculosis for 7 of 7 Days versus 5 of 7 Days in an In Vitro Pharmacodynamic System
por: Drusano, G. L., et al.
Publicado: (2011)

The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium tuberculosis as Determined in a Hollow-Fiber Infection Model
por: Drusano, G. L., et al.
Publicado: (2010)

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
por: Trieu, Lisa, et al.
Publicado: (2015)

Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India
por: Rathi, Varsha M, et al.
Publicado: (2020)

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients
por: Ishiguro, Nobuhisa, et al.
Publicado: (2017)

The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases
por: Sharma, Rahul, et al.
Publicado: (2013)

The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections
por: Chaftari, Anne-Marie, et al.
Publicado: (2014)

Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases
por: Olsson, Anna, et al.
Publicado: (2021)

Recent Advances in the Treatment and Prophylaxis of Leprosy
por: Rogers, Leonard
Publicado: (1930)

The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions
por: Pena, Maria Teresa, et al.
Publicado: (2022)

Postoperative endophthalmitis with and without intracameral moxifloxacin prophylaxis in a high volume surgery setting
por: Bhatta, Subash, et al.
Publicado: (2021)

Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk
por: Mkhize, Buyisile, et al.
Publicado: (2022)

T-Cell Regulation in Lepromatous Leprosy
por: Bobosha, Kidist, et al.
Publicado: (2014)

860. Immediate Access to Post-Exposure Prophylaxis (PEP) Through a 24/7 New York City PEP Hotline
por: Glaser, Allison, et al.
Publicado: (2018)

Human Beta-Defensin 3 Is Up-Regulated in Cutaneous Leprosy Type 1 Reactions
por: Cogen, Anna L., et al.
Publicado: (2012)

Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men
por: Valera, Pamela, et al.
Publicado: (2022)

Clinical features and microbiology of post-cataract surgery endophthalmitis with and without intracameral moxifloxacin prophylaxis: Endophthalmitis prophylaxis study report 3
por: Dave, Vivek P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o4kaqkp37qufov6l83ml0uh1vc